NXL stock news · Nexalin Technology
Get alerts for NXL
Follow Nexalin Technology (NXL) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for NXL12 health care stocks are changing a lot during Tuesday's trading.
NeutralNexalin Technology shares fell 20%, but the story gives no business update, so the move alone does not change its outlook.
On Friday, 12 health care stocks changed a lot in price during the day.
NeutralNexalin Technology's shares fell 25.2% during Friday's session. The article gives no company news behind the drop, so it does not change the business outlook.
12 health care stocks are changing a lot before the market opens on Friday.
NeutralNexalin Technology's shares fell 20% before Friday's open. The article gives no business news to explain the move, so it does not change the company's outlook.
Nexalin Technology, Inc. has signed an important deal to distribute its neurostimulation device in several Latin American countries.
Good for NXLNexalin signed an exclusive sales deal covering 7 South American countries. It opens a new sales route, but firm orders are limited and wider sales depend on meeting targets.
On Thursday, 12 health care stocks saw big price changes, with Nexalin Technology jumping up 77.8%.
NeutralNexalin Technology shares rose 77.8% in Thursday's session, but the article reports no company news behind the move, so it does not change the company's business outlook.
Nexalin Technology, Inc. announces the establishment of a significant definitive agreement (NXL).
NeutralNexalin Technology, Inc. has filed a Form 8-K indicating its entry into a material definitive agreement, which suggests a strategic move that could enhance its financial stability and operational capabilities. This development is likely to be viewed positively by investors as it may lead to growth opportunities.
Nexalin Technology, Inc. announces the establishment of a significant definitive agreement (NXL).
NeutralNexalin Technology, Inc. has filed a Form 8-K indicating its entry into a material definitive agreement, which is likely to create new opportunities for the company. This development is expected to have a positive impact on its stock as investors react to the potential for growth and strategic advancement.
Nexalin Technology, Inc. faces potential delisting after failing to meet ongoing listing criteria; listing transfer initiated (NXL).
Bad for NXLNexalin Technology, Inc. has filed a Form 8-K indicating that it has received a notice of delisting due to failure to satisfy continued listing standards. This news is significant as it raises concerns about the company's financial health and future viability in the market.